These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
154 related items for PubMed ID: 27177091
1. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways. Chen F, Chen X, Yang D, Che X, Wang J, Li X, Zhang Z, Wang Q, Zheng W, Wang L, Wang X, Song X. Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091 [Abstract] [Full Text] [Related]
4. Leflunomide Inhibits Proliferation and Induces Apoptosis via Suppressing Autophagy and PI3K/Akt Signaling Pathway in Human Bladder Cancer Cells. Cheng L, Wang H, Wang Z, Huang H, Zhuo D, Lin J. Drug Des Devel Ther; 2020 Jul; 14():1897-1908. PubMed ID: 32546957 [Abstract] [Full Text] [Related]
6. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G. Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279 [Abstract] [Full Text] [Related]
7. Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cells. Chen X, Gu N, Xue C, Li BR. Mol Med Rep; 2018 Feb 10; 17(2):3239-3245. PubMed ID: 29257319 [Abstract] [Full Text] [Related]
8. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway. He P, Wang Z, Sheng B, Xu Y, Feng S, Huang Y, Gong F, Tang L, Xie L. Histol Histopathol; 2020 Dec 10; 35(12):1511-1520. PubMed ID: 33372687 [Abstract] [Full Text] [Related]
9. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y, Li L, Huang M, Duan C, Zhang L, Chen J. Cell Signal; 2014 Dec 10; 26(12):2782-92. PubMed ID: 25193113 [Abstract] [Full Text] [Related]
10. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway. Zhang L, Wang CZ, Ma M, Shao GF. Eur Rev Med Pharmacol Sci; 2019 Oct 10; 23(20):8813-8822. PubMed ID: 31696468 [Abstract] [Full Text] [Related]
11. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway. Lv S, Wang W, Wang H, Zhu Y, Lei C. BMC Cancer; 2019 Mar 07; 19(1):204. PubMed ID: 30845932 [Abstract] [Full Text] [Related]
12. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways. Shin DY, Kim GY, Hwang HJ, Kim WJ, Choi YH. Environ Toxicol Pharmacol; 2014 Jan 07; 37(1):74-83. PubMed ID: 24309133 [Abstract] [Full Text] [Related]
14. Down-regulation of Rictor enhances cell sensitivity to PI3K inhibitor LY294002 by blocking mTORC2-medicated phosphorylation of Akt/PRAS40 in esophageal squamous cell carcinoma. Hou G, Zhao Q, Zhang M, Fan T, Liu M, Shi X, Ren Y, Wang Y, Zhou J, Lu Z. Biomed Pharmacother; 2018 Oct 07; 106():1348-1356. PubMed ID: 30119206 [Abstract] [Full Text] [Related]
15. The Flavonol Isoquercitrin Promotes Mitochondrial-Dependent Apoptosis in SK-Mel-2 Melanoma Cell via the PI3K/AKT/mTOR Pathway. Won YS, Kim JH, Lizardo RCM, Min HJ, Cho HD, Hong SM, Seo KI. Nutrients; 2020 Nov 29; 12(12):. PubMed ID: 33260329 [Abstract] [Full Text] [Related]
16. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer. Li X, Liu H, Lv C, Du J, Lian F, Zhang S, Wang Z, Zeng Y. Biomed Res Int; 2022 Nov 29; 2022():9304552. PubMed ID: 35402614 [Abstract] [Full Text] [Related]
17. Quinazoline based small molecule exerts potent tumour suppressive properties by inhibiting PI3K/Akt/FoxO3a signalling in experimental colon cancer. Qazi AK, Hussain A, Khan S, Aga MA, Behl A, Ali S, Singh SK, Taneja SC, Shah BA, Saxena AK, Mondhe DM, Hamid A. Cancer Lett; 2015 Apr 01; 359(1):47-56. PubMed ID: 25554016 [Abstract] [Full Text] [Related]
18. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARγ signalling pathway. Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, Ju L, Wu M, Xiao Y, Wang X. Sci Rep; 2016 Oct 25; 6():35783. PubMed ID: 27779188 [Abstract] [Full Text] [Related]
19. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Bian P, Hu W, Liu C, Li L. Arch Biochem Biophys; 2020 Aug 15; 689():108461. PubMed ID: 32531316 [Abstract] [Full Text] [Related]